These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 4533361

  • 1. Blood histamine in the differential diagnosis of myeloid splenomegaly (osteomyelofibrosis) and other myeloproliferative disorders.
    Gingold N.
    Rev Roum Med; 1974; 12(1):15-8. PubMed ID: 4533361
    [No Abstract] [Full Text] [Related]

  • 2. [Granulocyte clearance and granulocyte kinetics in myeloproliferative syndromes].
    Jungi WF, Meuret G, Senn HJ.
    Schweiz Med Wochenschr; 1974 Jan 26; 104(4):133-5. PubMed ID: 4521299
    [No Abstract] [Full Text] [Related]

  • 3. Studies on the phagocytic activity of neutrophilic leukocytes.
    Brandt L.
    Scand J Haematol Suppl; 1967 Jan 26; 2():1-126. PubMed ID: 5243720
    [No Abstract] [Full Text] [Related]

  • 4. Observations on the in vitro growth of peripheral leucocytes from patients with myeloproliferative disorders.
    Pegrum GD.
    Br J Haematol; 1966 Nov 26; 12(6):689-96. PubMed ID: 5224278
    [No Abstract] [Full Text] [Related]

  • 5. [On the existence of a myeloproliferative factor in patients with a myeloproliferative syndrome (author's transl)].
    Essers U, Nowak H.
    Blut; 1979 Aug 26; 39(2):107-15. PubMed ID: 289427
    [Abstract] [Full Text] [Related]

  • 6. Platelet function and arachidonate metabolism in patients with myeloproliferative disorders.
    Okuma M.
    Nihon Ketsueki Gakkai Zasshi; 1980 Dec 26; 43(6):1139-44. PubMed ID: 6800179
    [No Abstract] [Full Text] [Related]

  • 7. Platelet aggregation and platelet factor 3 activity in myeloproliferative disorders.
    Tangün Y.
    Thromb Diath Haemorrh; 1971 Jun 30; 25(2):241-51. PubMed ID: 5284903
    [No Abstract] [Full Text] [Related]

  • 8. A study of histamine in myeloproliferative disease.
    Gilbert HS, Warner RR, Wasserman LR.
    Blood; 1966 Dec 30; 28(6):795-806. PubMed ID: 5959473
    [No Abstract] [Full Text] [Related]

  • 9. Diagnosis and management of myeloproliferative disorders.
    Laszlo J, Huang AT.
    Curr Probl Cancer; 1977 Jul 30; 2(1):1-42. PubMed ID: 268266
    [No Abstract] [Full Text] [Related]

  • 10. [Clinical conference: Histaaminemia in myeloproliferative syndromes].
    Cadiou M, Ruff F, Meunier F, Attalah N, Bernadou A, Zittoun R, Parrot JL, Bousser J.
    Nouv Rev Fr Hematol; 1975 Jul 30; 15(2):261-9. PubMed ID: 126436
    [No Abstract] [Full Text] [Related]

  • 11. Phagocytosis in myeloproliferative disorders.
    Corberand J, LaHarrague P, De Larrard B, Nguyen F, Pris J.
    Am J Clin Pathol; 1980 Sep 30; 74(3):301-5. PubMed ID: 6932175
    [Abstract] [Full Text] [Related]

  • 12. Platelet and fibrinogen kinetics in the chronic myeloproliferative disorders.
    Brodsky I, Kahn SB, Ross EM, Petkov G.
    Cancer; 1972 Dec 30; 30(6):1444-50. PubMed ID: 4509103
    [No Abstract] [Full Text] [Related]

  • 13. Platelet defects in the myeloproliferative disorders.
    Inceman S, Tangün Y.
    Ann N Y Acad Sci; 1972 Oct 27; 201():251-61. PubMed ID: 4509685
    [No Abstract] [Full Text] [Related]

  • 14. [Radioimmunometric determination of histamine in myeloproliferative syndromes].
    Bettelheim P, Valent P.
    Wien Klin Wochenschr; 1989 Oct 27; 101(20):706-10. PubMed ID: 2480027
    [Abstract] [Full Text] [Related]

  • 15. Plasma fibronectin in idiopathic myelofibrosis and related chronic myeloproliferative disorders.
    Hasselbalch H, Clemmensen I.
    Scand J Clin Lab Invest; 1987 Sep 27; 47(5):429-33. PubMed ID: 3477850
    [Abstract] [Full Text] [Related]

  • 16. [Blood histamine level in chronic myeloproliferative diseases; a review].
    Gingold N.
    Onkologie; 1979 Apr 27; 2(2):70-4. PubMed ID: 392372
    [Abstract] [Full Text] [Related]

  • 17. [Characteristics of the morphology and function of the thrombocytes in myeloproliferative diseases].
    Petrov MN, Vashkinel' VK.
    Probl Gematol Pereliv Krovi; 1977 May 27; 22(5):18-23. PubMed ID: 267283
    [No Abstract] [Full Text] [Related]

  • 18. Intracellular growth factors in polycythemia vera and other myeloproliferative disorders.
    Eid J, Ebert RF, Gesell MS, Spivak JL.
    Proc Natl Acad Sci U S A; 1987 Jan 27; 84(2):532-6. PubMed ID: 3467372
    [Abstract] [Full Text] [Related]

  • 19. Megakaryocytes in cubital venous blood in patients with chronic myeloproliferative diseases.
    Tinggaard Pedersen N, Laursen B.
    Scand J Haematol; 1983 Jan 27; 30(1):50-8. PubMed ID: 6573016
    [Abstract] [Full Text] [Related]

  • 20. [Hemostasis disorders with reduced activity of the von Willebrand factor in myeloproliferative syndromes].
    Leupin L, Beck EA, Furlan M, Bucher U.
    Schweiz Med Wochenschr; 1983 May 14; 113(19):713-6. PubMed ID: 6603016
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.